Jardena Nordenberg

1.8k total citations
75 papers, 1.6k citations indexed

About

Jardena Nordenberg is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jardena Nordenberg has authored 75 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 18 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Jardena Nordenberg's work include Metabolism, Diabetes, and Cancer (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Telomeres, Telomerase, and Senescence (7 papers). Jardena Nordenberg is often cited by papers focused on Metabolism, Diabetes, and Cancer (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Telomeres, Telomerase, and Senescence (7 papers). Jardena Nordenberg collaborates with scholars based in Israel, United States and Japan. Jardena Nordenberg's co-authors include Einat Beery, Rivka Beitner, Lina Wasserman, Eyal Fenig, Abraham Novogrodsky, Tamar Cohen, Orit Uziel, Abraham Weizman, Meir Lahav and Yechezkel Sidi and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jardena Nordenberg

75 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jardena Nordenberg Israel 24 1.0k 267 234 219 140 75 1.6k
Anna Caselli Italy 23 1.2k 1.2× 265 1.0× 166 0.7× 282 1.3× 115 0.8× 51 1.9k
Bruna Pucci Italy 19 986 1.0× 289 1.1× 461 2.0× 153 0.7× 75 0.5× 26 1.9k
A K Hajra United States 27 1.8k 1.8× 155 0.6× 123 0.5× 264 1.2× 107 0.8× 49 2.6k
Silvia Borrello Italy 27 1.5k 1.4× 350 1.3× 221 0.9× 361 1.6× 95 0.7× 46 2.5k
Chun‐Yin Huang Taiwan 30 1.2k 1.2× 411 1.5× 463 2.0× 131 0.6× 126 0.9× 60 2.2k
Shigeki Tsuchida Japan 30 2.3k 2.2× 358 1.3× 631 2.7× 144 0.7× 180 1.3× 116 3.2k
Megumi Funakoshi‐Tago Japan 28 1.0k 1.0× 212 0.8× 398 1.7× 162 0.7× 189 1.4× 101 2.3k
Jerry J. Gipp United States 26 1.8k 1.8× 134 0.5× 278 1.2× 122 0.6× 80 0.6× 47 2.3k
Chia‐Ron Yang Taiwan 25 1.0k 1.0× 230 0.9× 316 1.4× 160 0.7× 80 0.6× 56 1.7k
Tae Hyeon Koo South Korea 12 721 0.7× 260 1.0× 130 0.6× 178 0.8× 39 0.3× 12 1.4k

Countries citing papers authored by Jardena Nordenberg

Since Specialization
Citations

This map shows the geographic impact of Jardena Nordenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jardena Nordenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jardena Nordenberg more than expected).

Fields of papers citing papers by Jardena Nordenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jardena Nordenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jardena Nordenberg. The network helps show where Jardena Nordenberg may publish in the future.

Co-authorship network of co-authors of Jardena Nordenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jardena Nordenberg. A scholar is included among the top collaborators of Jardena Nordenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jardena Nordenberg. Jardena Nordenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beery, Einat, Jardena Nordenberg, Uri Rozovski, et al.. (2019). The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells. International Journal of Molecular Sciences. 20(10). 2509–2509. 6 indexed citations
2.
Gutkin, Anna, Orit Uziel, Einat Beery, et al.. (2016). Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells. Oncotarget. 7(37). 59173–59188. 104 indexed citations
3.
Uziel, Orit, Amiram Ravid, Ina Fabian, et al.. (2008). Oxidative stress causes telomere damage in Fanconi anaemia cells – a possible predisposition for malignant transformation. British Journal of Haematology. 142(1). 82–93. 29 indexed citations
4.
Yerushalmi, Rinat, Jardena Nordenberg, Einat Beery, et al.. (2007). Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro.. PubMed. 29(2). 126–31. 18 indexed citations
5.
Gil‐Ad, Irit, Biana Shtaif, Yechiel Levkovitz, et al.. (2006). Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncology Reports. 15(1). 107–12. 67 indexed citations
6.
Nordenberg, Jardena, et al.. (2000). Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?. Cancer Letters. 161(1). 27–34. 28 indexed citations
7.
Nordenberg, Jardena, et al.. (1999). Effects of psychotropic drugs on cell proliferation and differentiation. Biochemical Pharmacology. 58(8). 1229–1236. 91 indexed citations
8.
Fenig, Eyal, Lina Wasserman, Einat Beery, et al.. (1999). Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells. Journal of Cancer Research and Clinical Oncology. 125(10). 556–562. 12 indexed citations
9.
Donin, Natalie, et al.. (1995). Role of immune response as determinant of tumor progression in function of host age in the B16 melanoma. Mechanisms of Ageing and Development. 80(2). 121–137. 12 indexed citations
10.
Landau, Ofer, Lina Wasserman, Assaf Deutsch, et al.. (1993). Amino acid alcohols: growth inhibition and induction of differentiated features in melanoma cells. Cancer Letters. 69(3). 203–208. 2 indexed citations
11.
Arber, Nadir, G. Zajicek, Jardena Nordenberg, & Yechezkel Sidi. (1991). Azathioprine treatment increases hepatocyte turnover. Gastroenterology. 101(4). 1083–1086. 16 indexed citations
12.
Nordenberg, Jardena, Lina Wasserman, Haim Gutman, Einat Beery, & Abraham Novogrodsky. (1989). Growth inhibition and induction of phenotypic alterations by l-histidinol in B16 mouse melanoma cells. Cancer Letters. 47(3). 193–197. 9 indexed citations
13.
Sidi, Yechezkel, et al.. (1989). Growth inhibition and induction of phenotypic alterations by tiazofurin: Differential effects on MCF-7 breast cancer and HBL-100 breast cell lines. European Journal of Cancer and Clinical Oncology. 25(5). 883–889. 12 indexed citations
14.
Aviram, Rami, Alexander Deutsch, Miriam Patya, et al.. (1988). Biochemical tissue markers of human colorectal carcinoma. Diseases of the Colon & Rectum. 31(3). 176–180. 5 indexed citations
15.
16.
17.
Nordenberg, Jardena, Kurt H. Stenzel, & Abraham Novogrodsky. (1984). The Na+-ionophore monensin enhances glucose uptake in mouse thymocytes. International Journal of Biochemistry. 16(7). 837–840. 1 indexed citations
18.
Beitner, Rivka, Jardena Nordenberg, & Tamar Cohen. (1979). Correlation between the levels of glucose 1,6-diphosphate and the activities of phosphofructokinase, phosphoglucomutase and hexokinase, in skeletal and heart muscles from rats of different ages. International Journal of Biochemistry. 10(7). 603–608. 32 indexed citations
19.
Beitner, Rivka & Jardena Nordenberg. (1979). The regulatory role of glucose 1,6‐diphosphate in muscle of dystrophic mice. FEBS Letters. 98(1). 199–202. 33 indexed citations
20.
Beitner, Rivka, Sol Haberman, & Jardena Nordenberg. (1978). The effect of epinephrine and dibutyryl cyclic AMP on glucose 1,6-bisphosphate levels and the activities of hexokinase, phosphofructokinase and phosphoglucomutase in the isolated rat diaphragm. Molecular and Cellular Endocrinology. 10(2). 135–147. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Caselli Breakdown of academic impact, for papers by Bruna Pucci Breakdown of academic impact, for papers by A K Hajra Breakdown of academic impact, for papers by Silvia Borrello Breakdown of academic impact, for papers by Chun‐Yin Huang Breakdown of academic impact, for papers by Shigeki Tsuchida Breakdown of academic impact, for papers by Megumi Funakoshi‐Tago Breakdown of academic impact, for papers by Jerry J. Gipp Breakdown of academic impact, for papers by Chia‐Ron Yang Breakdown of academic impact, for papers by Tae Hyeon Koo
Rankless by CCL
2026